NCT06639074 2025-10-02
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
9 trialsNCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
NCT03848182 2024-04-18
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer
Albert Einstein College of Medicine
Phase 2 Terminated
NCT02700841 2024-03-12
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
University of Nebraska
Phase 2 Terminated
NCT00639639 2023-03-13
ATTAC
Duke University
Phase 1 Completed
NCT02864368 2022-06-09
PERFORMANCE
Duke University
Phase 1 Terminated
NCT01644968 2022-05-17
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Providence Health & Services
Phase 1 Completed
NCT01611298 2020-04-21
TAR
Baylor College of Medicine
Phase NA Completed
NCT00369291 2017-11-29
CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
Phase 1 Terminated